http://hl7.eu/fhir/ig/gravitate-health/Bundle/bundlepackageleaflet-en-660952efa1b907b97e182807063ac261
type: Bundle
node role: treeRoot
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi
    l: Bundle-uv-epi
language:
  v: en
identifier:
  system:
    v: https://www.gravitatehealth.eu/sid/doc
    l: doc
type:
  v: document
timestamp:
  v: 2023-06-27T10:09:22Z
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-en-245a2b4a9e3ee4304e5e6cf2b1a252b4
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-simvastatine-titaniumdioxide
    l: ingredient-for-simvastatine-titaniumdioxide
  resource: ingredient-for-simvastatine-titaniumdioxide
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-simvastatine-hypromelloseunspecified
    l: ingredient-for-simvastatine-hypromelloseunspecified
  resource: ingredient-for-simvastatine-hypromelloseunspecified
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-simvastatine-simvastatin
    l: ingredient-for-simvastatine-simvastatin
  resource: ingredient-for-simvastatine-simvastatin
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/SubstanceDefinition/substance-simvastatin
    l: substance-simvastatin
  resource: substance-simvastatin
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/AdministrableProductDefinition/ap-660952efa1b907b97e182807063ac261
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorization660952efa1b907b97e182807063ac2610
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Organization/mah-1f2bde1de64d7b561417b3a3d4313827
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-eac96261823092966bc3d7659feb5d7a
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/MedicinalProductDefinition/mp245a2b4a9e3ee4304e5e6cf2b1a252b4
    l: mp245a2b4a9e3ee4304e5e6cf2b1a252b4
  resource: mp245a2b4a9e3ee4304e5e6cf2b1a252b4
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/mid-660952efa1b907b97e182807063ac261

http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-en-245a2b4a9e3ee4304e5e6cf2b1a252b4
type: Composition
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi
    l: Composition-uv-epi
language:
  v: en
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Composition composition-en-245a2b4a9e3ee4304e5e6cf2b1a252b4 Language: en Profile: Composition (ePI) identifier: https://spor.ema.europa.eu/rmswi//33baa39274e4f9e04535de6e365fb5af status: Final type: Package Leaflet category: Raw date: 2022-02-16 13:28:17+0000 author: Organization Sandoz A/S title: TEST PURPOSES ONLY - Lipcut Simvastatin 5 mg Tablet Attesters - Mode Time * Official 2022-02-16 13:28:17+0000
identifier:
  system:
    v: https://spor.ema.europa.eu/rmswi/
    l: rmswi
status:
  v: final
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi/
      l: rmswi
    code:
      v: 100000155538
  text:
    v: Package Leaflet
category:
  coding:
    system:
      v: http://hl7.eu/fhir/ig/gravitate-health/CodeSystem/epicategory-cs
      l: epicategory-cs
    code:
      v: R
    display:
      v: Raw
subject:
  l: mp245a2b4a9e3ee4304e5e6cf2b1a252b4
date:
  v: 2022-02-16T13:28:17Z
title:
  v: TEST PURPOSES ONLY - Lipcut Simvastatin 5 mg Tablet
attester:
  mode:
    coding:
      system:
        v: http://hl7.org/fhir/composition-attestation-mode
        l: composition-attestation-mode
      code:
        v: official
  time:
    v: 2022-02-16T13:28:17Z
section:
  title:
    v: B. Package Leaflet
  code:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi/
        l: rmswi
      code:
        v: 100000155538
    text:
      v: B. Package Leaflet
  text:
    status:
      v: additional
    div:
      v: unavailable
  empty reason:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/list-empty-reason
        l: list-empty-reason
      code:
        v: unavailable
  section:
    title:
      v: Package leaflet: Information for the user
    code:
      text:
        v: Package leaflet: Information for the user
    text:
      status:
        v: additional
      div:
        v: unavailable
  section:
    title:
      v: What is in this leaflet
    code:
      text:
        v: What is in this leaflet
    text:
      status:
        v: additional
      div:
        v: unavailable
  section:
    title:
      v: 1. What Lipcut Simvastatin 5 mg Tablet is and what it is used for
    code:
      text:
        v: 1. What Lipcut Simvastatin 5 mg Tablet is and what it is used for
    text:
      status:
        v: additional
      div:
        v: unavailable
  section:
    title:
      v: 2. What you need to know before you take Lipcut Simvastatin 5 mg Tablet
    code:
      text:
        v: 2. What you need to know before you take Lipcut Simvastatin 5 mg Tablet
    text:
      status:
        v: additional
      div:
        v: unavailable
  section:
    title:
      v: 3. How to take Lipcut Simvastatin 5 mg Tablet
    code:
      text:
        v: 3. How to take Lipcut Simvastatin 5 mg Tablet
    text:
      status:
        v: additional
      div:
        v: unavailable
  section:
    title:
      v: 4. Possible side effects
    code:
      text:
        v: 4. Possible side effects
    text:
      status:
        v: additional
      div:
        v: unavailable
  section:
    title:
      v: 5. How to store Lipcut Simvastatin 5 mg Tablet
    code:
      text:
        v: 5. How to store Lipcut Simvastatin 5 mg Tablet
    text:
      status:
        v: additional
      div:
        v: unavailable
  section:
    title:
      v: 6. Contents of the pack and other information
    code:
      text:
        v: 6. Contents of the pack and other information
    text:
      status:
        v: additional
      div:
        v: unavailable

ingredient-for-simvastatine-titaniumdioxide
type: Ingredient
id:
  v: ingredient-for-simvastatine-titaniumdioxide
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi
    l: Ingredient-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Ingredient ingredient-for-simvastatine-titaniumdioxide Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/15FIX9V2JP (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#fin-x (use: official, ); status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet MedicinalProductDefinition: identifier = https://www.who-umc.org/phpid#F92168108C432D63DACDD70444176BB3; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#fin-x; status = active; administrableDoseForm = Tablet; unitOfPresentation = Tablet role: Excipient substance Codes - Concept * TITANIUM DIOXIDE
identifier:
  use:
    v: official
  system:
    v: https://gsrs.ncats.nih.gov/ginas/app/beta
    l: beta
  value:
    v: 15FIX9V2JP
status:
  v: active
for:
  l: mp245a2b4a9e3ee4304e5e6cf2b1a252b4
role:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000072082
    display:
      v: Excipient

ingredient-for-simvastatine-hypromelloseunspecified
type: Ingredient
id:
  v: ingredient-for-simvastatine-hypromelloseunspecified
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi
    l: Ingredient-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Ingredient ingredient-for-simvastatine-hypromelloseunspecified Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/3NXW29V3WO (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#fin-x (use: official, ); status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet MedicinalProductDefinition: identifier = https://www.who-umc.org/phpid#F92168108C432D63DACDD70444176BB3; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#fin-x; status = active; administrableDoseForm = Tablet; unitOfPresentation = Tablet role: Excipient substance Codes - Concept * HYPROMELLOSE, UNSPECIFIED
identifier:
  use:
    v: official
  system:
    v: https://gsrs.ncats.nih.gov/ginas/app/beta
    l: beta
  value:
    v: 3NXW29V3WO
status:
  v: active
for:
  l: mp245a2b4a9e3ee4304e5e6cf2b1a252b4
role:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000072082
    display:
      v: Excipient

ingredient-for-simvastatine-simvastatin
type: Ingredient
id:
  v: ingredient-for-simvastatine-simvastatin
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi
    l: Ingredient-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Ingredient ingredient-for-simvastatine-simvastatin Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/AGG2FN16EV (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#fin-x (use: official, ); status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet MedicinalProductDefinition: identifier = https://www.who-umc.org/phpid#F92168108C432D63DACDD70444176BB3; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#fin-x; status = active; administrableDoseForm = Tablet; unitOfPresentation = Tablet role: Active substance Codes - Concept * SIMVASTATIN Strengths - Presentation[x] Basis * 5 mg (Details: UCUM codemg = 'mg') active ingredient - basis of strength
identifier:
  use:
    v: official
  system:
    v: https://gsrs.ncats.nih.gov/ginas/app/beta
    l: beta
  value:
    v: AGG2FN16EV
status:
  v: active
for:
  l: mp245a2b4a9e3ee4304e5e6cf2b1a252b4
role:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000072072
    display:
      v: Active
substance:
  strength:
    presentation: Quantity
      value:
        v: 5
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: mg

substance-simvastatin
type: SubstanceDefinition
id:
  v: substance-simvastatin
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi
    l: SubstanceDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: SubstanceDefinition substance-simvastatin Profile: SubstanceDefinition (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta//AGG2FN16EV (use: official, ) status: Active manufacturer: Organization Sandoz A/S
identifier:
  use:
    v: official
  system:
    v: https://gsrs.ncats.nih.gov/ginas/app/beta/
    l: beta
  value:
    v: AGG2FN16EV
status:
  coding:
    system:
      v: http://hl7.org/fhir/publication-status
      l: publication-status
    code:
      v: active

http://hl7.eu/fhir/ig/gravitate-health/AdministrableProductDefinition/ap-660952efa1b907b97e182807063ac261
type: AdministrableProductDefinition
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi
    l: AdministrableProductDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: AdministrableProductDefinition ap-660952efa1b907b97e182807063ac261 Profile: AdministrableProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/fin-x status: Active formOf: MedicinalProductDefinition: identifier = https://www.who-umc.org/phpid#F92168108C432D63DACDD70444176BB3; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription administrableDoseForm: Tablet unitOfPresentation: Tablet producedFrom: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#fin-x (use: official, ); status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet routeOfAdministration code: Oral use TargetSpecies - Code * Human
identifier:
  system:
    v: https://spor.ema.europa.eu/pmswi
    l: pmswi
  value:
    v: fin-x
status:
  v: active
form of:
  l: mp245a2b4a9e3ee4304e5e6cf2b1a252b4
administrable dose form:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000073664
    display:
      v: Tablet
unit of presentation:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 200000002152
    display:
      v: Tablet
route of administration:
  code:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi
        l: rmswi
      code:
        v: 100000073619
      display:
        v: Oral use

http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorization660952efa1b907b97e182807063ac2610
type: RegulatedAuthorization
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi
    l: RegulatedAuthorization-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: RegulatedAuthorization authorization660952efa1b907b97e182807063ac2610 Profile: RegulatedAuthorization (ePI) identifier: https://spor.ema.europa.eu/pmswi/fin-x (use: official, ) subject: MedicinalProductDefinition: identifier = https://www.who-umc.org/phpid#F92168108C432D63DACDD70444176BB3; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription type: Marketing Authorisation status: Active statusDate: 2015-02-07 13:28:17+0000 holder: Organization Sandoz A/S
identifier:
  use:
    v: official
  system:
    v: https://spor.ema.europa.eu/pmswi
    l: pmswi
  value:
    v: fin-x
subject:
  l: mp245a2b4a9e3ee4304e5e6cf2b1a252b4
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 220000000061
    display:
      v: Marketing Authorisation
status:
  coding:
    system:
      v: http://hl7.org/fhir/publication-status
      l: publication-status
    code:
      v: active
    display:
      v: Active
status date:
  v: 2015-02-07T13:28:17Z

http://hl7.eu/fhir/ig/gravitate-health/Organization/mah-1f2bde1de64d7b561417b3a3d4313827
type: Organization
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi
    l: Organization-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Organization mah-1f2bde1de64d7b561417b3a3d4313827 Profile: Organization (ePI) identifier: https://spor.ema.europa.eu/omswi/ORG-100000848 (use: official, ) active: true type: Marketing authorisation holder name: Sandoz A/S Contacts - Address * Edvard Thomsens Vej 14 Copenhagen S DK(work)
identifier:
  use:
    v: official
  system:
    v: https://spor.ema.europa.eu/omswi
    l: omswi
  value:
    v: ORG-100000848
active:
  v: true
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 220000000034
    display:
      v: Marketing authorisation holder
name:
  v: Sandoz A/S
contact:
  address:
    use:
      v: work
    type:
      v: physical
    text:
      v: Edvard Thomsens Vej 14 Copenhagen S DK
    line:
      v: Edvard Thomsens Vej 14
    city:
      v: Copenhagen S
    postal code:
      v: 2300
    country:
      v: DK

http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-eac96261823092966bc3d7659feb5d7a
type: PackagedProductDefinition
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi
    l: PackagedProductDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: PackagedProductDefinition ppd-eac96261823092966bc3d7659feb5d7a Profile: PackagedProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/fin-x (use: official, ) name: Lipcut Simvastatin 5 mg Tablet 28 type: Chemical Medicinal Product packageFor: MedicinalProductDefinition: identifier = https://www.who-umc.org/phpid#F92168108C432D63DACDD70444176BB3; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription status: Active statusDate: 2015-02-07 13:28:17+0000 containedItemQuantity: 5 mg (Details: UCUM codemg = 'mg') packaging type: Box quantity: 1 material: Cardboard packaging identifier: https://spor.ema.europa.eu/pmswi/123456 type: Blister quantity: 28 material: PolyVinyl Chloride containedItem Items - Reference * ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#fin-x (use: official, ); status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet
identifier:
  use:
    v: official
  system:
    v: https://spor.ema.europa.eu/pmswi
    l: pmswi
  value:
    v: fin-x
name:
  v: Lipcut Simvastatin 5 mg Tablet 28
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000155527
    display:
      v: Chemical Medicinal Product
package for:
  l: mp245a2b4a9e3ee4304e5e6cf2b1a252b4
status:
  coding:
    system:
      v: http://hl7.org/fhir/publication-status
      l: publication-status
    code:
      v: active
    display:
      v: Active
status date:
  v: 2015-02-07T13:28:17Z
contained item quantity:
  value:
    v: 5
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org
  code:
    v: mg
packaging:
  type:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi
        l: rmswi
      code:
        v: 100000073498
      display:
        v: Box
  quantity:
    v: 1
  material:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi
        l: rmswi
      code:
        v: 200000003529
      display:
        v: Cardboard
  packaging:
    identifier:
      system:
        v: https://spor.ema.europa.eu/pmswi
        l: pmswi
      value:
        v: 123456
    quantity:
      v: 28

mp245a2b4a9e3ee4304e5e6cf2b1a252b4
type: MedicinalProductDefinition
id:
  v: mp245a2b4a9e3ee4304e5e6cf2b1a252b4
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi
    l: MedicinalProductDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicinalProductDefinition mp245a2b4a9e3ee4304e5e6cf2b1a252b4 Profile: MedicinalProductDefinition (ePI) identifier: https://www.who-umc.org/phpid/F92168108C432D63DACDD70444176BB3 type: Medicinal Product domain: Human use status: active legalStatusOfSupply: Medicinal product subject to medical prescription name productName: Lipcut Simvastatin 5 mg Tablet type: Full name part part: Lipcut type: Invented name part part part: Simvastatin type: Scientific name part part part: 5 mg type: Strength part part part: tablet type: Pharmaceutical dose form part Usages - Country Jurisdiction Language * Finland Finland English
identifier:
  system:
    v: https://www.who-umc.org/phpid
    l: phpid
type:
  coding:
    system:
      v: http://hl7.org/fhir/medicinal-product-type
      l: medicinal-product-type
    code:
      v: MedicinalProduct
    display:
      v: Medicinal Product
domain:
  coding:
    system:
      v: http://hl7.org/fhir/medicinal-product-domain
      l: medicinal-product-domain
    code:
      v: Human
    display:
      v: Human use
status:
  coding:
    system:
      v: http://hl7.org/fhir/publication-status
      l: publication-status
    code:
      v: active
    display:
      v: active
legal status of supply:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000072084
    display:
      v: Medicinal product subject to medical prescription
name:
  product name:
    v: Lipcut Simvastatin 5 mg Tablet
  type:
    coding:
      system:
        v: https://spor.ema.europa.eu/lists/220000000000
        l: https://spor.ema.europa.eu/lists/220000000000
      code:
        v: 220000000001
      display:
        v: Full name
  part:
    part:
      v: Lipcut
  part:
    part:
      v: Simvastatin
  part:
    part:
      v: 5 mg
  part:
    part:
      v: tablet

http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/mid-660952efa1b907b97e182807063ac261
type: ManufacturedItemDefinition
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi
    l: ManufacturedItemDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: ManufacturedItemDefinition mid-660952efa1b907b97e182807063ac261 Profile: ManufacturedItemDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/fin-x (use: official, ) status: Active manufacturedDoseForm: Tablet unitOfPresentation: Tablet
identifier:
  use:
    v: official
  system:
    v: https://spor.ema.europa.eu/pmswi
    l: pmswi
  value:
    v: fin-x
status:
  v: active
manufactured dose form:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi/
      l: rmswi
    code:
      v: 100000073664
    display:
      v: Tablet
unit of presentation:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 200000002152
    display:
      v: Tablet

v: 100000155538

v: unavailable

v: 100000155538

v: unavailable

v: 100000155538

v: unavailable

v: 100000155538

v: unavailable

v: 100000155538

v: unavailable

v: 100000155538

v: unavailable

v: 100000155538

v: unavailable

v: 100000155538

v: unavailable

v: 15FIX9V2JP

v: TITANIUM DIOXIDE

v: 3NXW29V3WO

v: HYPROMELLOSE, UNSPECIFIED

v: AGG2FN16EV

v: SIMVASTATIN

v: ACTIB

v: active ingredient - basis of strength

v: 100000109093

v: Human

v: 100000073496

v: Blister

v: 200000003222

v: PolyVinyl Chloride

v: 220000000002

v: Invented name part

v: 220000000003

v: Scientific name part

v: 220000000004

v: Strength part

v: 220000000005

v: Pharmaceutical dose form part

v: urn:iso:std:iso:3166
l: 3166

v: FIN

v: Finland

v: urn:iso:std:iso:3166
l: 3166

v: FIN

v: Finland

v: urn:ietf:bcp:47
l: 47

v: en

v: English